Detailed information for compound 172202

Basic information

Technical information
  • Name: Unnamed compound
  • MW: 506.398 | Formula: C24H24BrN7O
  • H donors: 1 H acceptors: 5 LogP: 3.62 Rotable bonds: 5
    Rule of 5 violations (Lipinski): 2
  • SMILES: CCOC1CCN(CC1)c1ccc(nn1)c1nc2ncnc(c2c(c1)c1cccc(c1)Br)N
  • InChi: 1S/C24H24BrN7O/c1-2-33-17-8-10-32(11-9-17)21-7-6-19(30-31-21)20-13-18(15-4-3-5-16(25)12-15)22-23(26)27-14-28-24(22)29-20/h3-7,12-14,17H,2,8-11H2,1H3,(H2,26,27,28,29)
  • InChiKey: PEQMJYWMTZTCRI-UHFFFAOYSA-N  

Network

Hover on a compound node to display the structore

Synonyms

No synonyms found for this compound

Targets

Known targets for this compound

Species Target name Source Bibliographic reference
Homo sapiens adenosine kinase Starlite/ChEMBL References

Predicted pathogen targets for this compound

By orthology
Species Potential target Known druggable target/s Ortholog Group
Neospora caninum GG10762, related Get druggable targets OG5_128398 All targets in OG5_128398
Schistosoma japonicum ko:K00856 adenosine kinase [EC2.7.1.20], putative Get druggable targets OG5_128398 All targets in OG5_128398
Cryptosporidium parvum adenosine kinase like ribokinase Get druggable targets OG5_128398 All targets in OG5_128398
Leishmania mexicana adenosine kinase, putative Get druggable targets OG5_128398 All targets in OG5_128398
Trypanosoma cruzi adenosine kinase, putative Get druggable targets OG5_128398 All targets in OG5_128398
Trypanosoma cruzi adenosine kinase, putative Get druggable targets OG5_128398 All targets in OG5_128398
Schistosoma mansoni adenosine kinase Get druggable targets OG5_128398 All targets in OG5_128398
Leishmania donovani adenosine kinase, putative Get druggable targets OG5_128398 All targets in OG5_128398
Leishmania infantum adenosine kinase, putative Get druggable targets OG5_128398 All targets in OG5_128398
Trypanosoma brucei gambiense adenosine kinase, putative Get druggable targets OG5_128398 All targets in OG5_128398
Leishmania braziliensis adenosine kinase, putative Get druggable targets OG5_128398 All targets in OG5_128398
Loa Loa (eye worm) hypothetical protein Get druggable targets OG5_128398 All targets in OG5_128398
Trypanosoma brucei adenosine kinase, putative Get druggable targets OG5_128398 All targets in OG5_128398
Candida albicans adenosine kinase Get druggable targets OG5_128398 All targets in OG5_128398
Candida albicans putative adenosine kinase Get druggable targets OG5_128398 All targets in OG5_128398
Echinococcus granulosus adenosine kinase Get druggable targets OG5_128398 All targets in OG5_128398
Trypanosoma brucei adenosine kinase, putative Get druggable targets OG5_128398 All targets in OG5_128398
Leishmania major adenosine kinase, putative Get druggable targets OG5_128398 All targets in OG5_128398
Trypanosoma brucei gambiense adenosine kinase, putative Get druggable targets OG5_128398 All targets in OG5_128398
Toxoplasma gondii kinase, pfkB family protein Get druggable targets OG5_128398 All targets in OG5_128398
Echinococcus multilocularis adenosine kinase Get druggable targets OG5_128398 All targets in OG5_128398
Babesia bovis adenosine kinase Get druggable targets OG5_128398 All targets in OG5_128398
Brugia malayi Adenosine kinase-like Get druggable targets OG5_128398 All targets in OG5_128398
Trypanosoma congolense adenosine kinase, putative Get druggable targets OG5_128398 All targets in OG5_128398
Schistosoma mansoni adenosine kinase Get druggable targets OG5_128398 All targets in OG5_128398
Onchocerca volvulus Get druggable targets OG5_128398 All targets in OG5_128398

By sequence similarity to non orthologous known druggable targets
Species Potential target Known druggable target Length Alignment span Identity
Trypanosoma cruzi adenosine kinase, putative adenosine kinase 345 aa 337 aa 35.6 %

Obtained from network model

Ranking Plot


Putative Targets List


Species Potential target Raw Global Species
Loa Loa (eye worm) hypothetical protein 0.0365 0.2915 0.2823
Loa Loa (eye worm) hypothetical protein 0.0365 0.2915 0.2823
Schistosoma mansoni hypothetical protein 0.1027 1 1
Onchocerca volvulus 0.1027 1 1
Toxoplasma gondii DNA topoisomerase domain-containing protein 0.1027 1 1
Schistosoma mansoni fusion 0.0365 0.2915 0.2823
Onchocerca volvulus 0.0365 0.2915 0.2915
Echinococcus granulosus ring and YY1 binding protein 0.0365 0.2915 0.2823
Plasmodium vivax hypothetical protein, conserved 0.1027 1 0.5
Trypanosoma cruzi Zn-finger in Ran binding protein and others/FYVE zinc finger, putative 0.0365 0.2915 1
Brugia malayi Zn-finger in Ran binding protein and others containing protein 0.0365 0.2915 0.2823
Loa Loa (eye worm) hypothetical protein 0.0365 0.2915 0.2823
Schistosoma mansoni hypothetical protein 0.0365 0.2915 0.2823
Brugia malayi SWIB/MDM2 domain containing protein 0.1027 1 1
Onchocerca volvulus Ubiquitin thioesterase ZRANB1 homolog 0.0365 0.2915 0.2915
Trypanosoma cruzi Zn-finger in Ran binding protein and others, putative 0.0365 0.2915 1
Toxoplasma gondii SWIB/MDM2 domain-containing protein 0.1027 1 1
Echinococcus multilocularis SWI:SNF matrix associated 0.1027 1 1
Plasmodium vivax SWIB/MDM2 domain-containing protein, putative 0.1027 1 0.5
Loa Loa (eye worm) brahma associated protein 0.1027 1 1
Leishmania major hypothetical protein, conserved 0.0365 0.2915 1
Trypanosoma cruzi mitochondrial RNA binding complex 1 subunit, putative 0.0365 0.2915 1
Loa Loa (eye worm) hypothetical protein 0.0365 0.2915 0.2823
Trypanosoma cruzi mitochondrial RNA binding complex 1 subunit, putative 0.0365 0.2915 1
Onchocerca volvulus 0.0365 0.2915 0.2915
Plasmodium falciparum SWIB/MDM2 domain-containing protein 0.1027 1 1
Schistosoma mansoni TRABID protein (C64 family) 0.0365 0.2915 0.2823
Brugia malayi Zn-finger in Ran binding protein and others containing protein 0.0365 0.2915 0.2823
Trypanosoma brucei mitochondrial RNA binding complex 1 subunit 0.0365 0.2915 1
Trichomonas vaginalis conserved hypothetical protein 0.1027 1 0.5
Echinococcus multilocularis SWI:SNF matrix associated 0.1027 1 1
Leishmania major hypothetical protein, conserved 0.0365 0.2915 1
Echinococcus multilocularis Nuclear pore complex protein Nup153 0.0365 0.2915 0.2823
Schistosoma mansoni brg-1 associated factor 0.1027 1 1
Toxoplasma gondii ran binding protein 0.0365 0.2915 0.2823
Trypanosoma cruzi hypothetical protein, conserved 0.0365 0.2915 1
Brugia malayi YY1-associated factor 2 0.0365 0.2915 0.2823
Schistosoma mansoni zinc finger protein 0.0365 0.2915 0.2823
Chlamydia trachomatis DNA topoisomerase I 0.1027 1 0.5
Echinococcus granulosus Nuclear pore complex protein Nup153 0.0365 0.2915 0.2823
Brugia malayi brahma associated protein 60 kDa 0.1027 1 1
Trypanosoma cruzi hypothetical protein, conserved 0.0365 0.2915 1
Trypanosoma cruzi hypothetical protein, conserved 0.0365 0.2915 1
Echinococcus multilocularis SWI:SNF matrix associated 0.1027 1 1
Leishmania major hypothetical protein, conserved 0.0365 0.2915 1
Echinococcus granulosus Upstream activation factor subunit UAF30 0.1027 1 1
Loa Loa (eye worm) hypothetical protein 0.0365 0.2915 0.2823
Echinococcus multilocularis Upstream activation factor subunit UAF30 0.1027 1 1
Trypanosoma brucei hypothetical protein, conserved 0.0365 0.2915 1
Echinococcus granulosus SWI:SNF matrix associated 0.1027 1 1
Loa Loa (eye worm) SWIB/MDM2 domain-containing protein 0.1027 1 1
Chlamydia trachomatis SWIB complex protein 0.1027 1 0.5
Brugia malayi Zn-finger in Ran binding protein and others containing protein 0.0365 0.2915 0.2823
Trypanosoma cruzi WLM domain containing protein, putative 0.0365 0.2915 1
Echinococcus granulosus Zinc finger RanBP2 type 0.0365 0.2915 0.2823
Onchocerca volvulus 0.0365 0.2915 0.2915
Brugia malayi Zn-finger in Ran binding protein and others containing protein 0.0365 0.2915 0.2823
Echinococcus granulosus zinc finger protein Ran binding 0.0365 0.2915 0.2823
Trypanosoma cruzi WLM domain containing protein, putative 0.0365 0.2915 1
Leishmania major hypothetical protein, conserved 0.0365 0.2915 1
Echinococcus multilocularis Zinc finger, RanBP2 type 0.0365 0.2915 0.2823
Schistosoma mansoni hypothetical protein 0.1027 1 1
Plasmodium falciparum SWIB/MDM2 domain-containing protein 0.1027 1 1
Onchocerca volvulus 0.0365 0.2915 0.2915
Trypanosoma cruzi Zn-finger in Ran binding protein and others, putative 0.0365 0.2915 1
Echinococcus multilocularis zinc finger protein Ran binding 0.0365 0.2915 0.2823
Echinococcus multilocularis ring and YY1 binding protein 0.0365 0.2915 0.2823
Toxoplasma gondii Zn-finger in Ran binding protein and others domain-containing protein 0.0365 0.2915 0.2823
Schistosoma mansoni RNA binding protein 0.0365 0.2915 0.2823
Leishmania major hypothetical protein, conserved 0.0365 0.2915 1
Trypanosoma brucei Zn-finger in Ran binding protein and others/FYVE zinc finger, putative 0.0365 0.2915 1
Trypanosoma brucei hypothetical protein, conserved 0.0365 0.2915 1
Schistosoma mansoni hypothetical protein 0.1027 1 1

Activities

Activity type Activity value Assay description Source Reference
ED50 (functional) = 7 uM kg-1 Effective dose to reduce pain in carregenin induced thermal hyperalgesia assay in rat was determined ChEMBL. 12941329
ED50 (functional) = 20 uM kg-1 Effective dose to reduce locomotor side effects in animals was determined ChEMBL. 12941329
IC50 (binding) = 10.4 nM Inhibitory concentration against adenosine kinase was determined ChEMBL. 12941329
IC50 (binding) = 10.4 nM Inhibitory concentration against adenosine kinase was determined ChEMBL. 12941329
IC50 (binding) = 51.7 nM Inhibitory concentration against adenosine kinase was determined in cell assay ChEMBL. 12941329
IC50 (binding) = 51.7 nM Inhibitory concentration against adenosine kinase was determined in cell assay ChEMBL. 12941329

Phenotypes

Whole-cell/tissue/organism interactions

We have no records of whole-cell/tissue assays done with this compound What does this mean?

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

We have no manually annotated phenotypes for this drug. What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
 
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.

External resources for this compound

Bibliographic References

1 literature reference was collected for this gene.

If you have references for this compound, please enter them in a user comment (below) or Contact us.